358 related articles for article (PubMed ID: 19172989)
1. Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging.
Rodriguez S; Coppedè F; Sagelius H; Eriksson M
Eur J Hum Genet; 2009 Jul; 17(7):928-37. PubMed ID: 19172989
[TBL] [Abstract][Full Text] [Related]
2. Hutchinson-Gilford progeria syndrome.
Pollex RL; Hegele RA
Clin Genet; 2004 Nov; 66(5):375-81. PubMed ID: 15479179
[TBL] [Abstract][Full Text] [Related]
3. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel RNA isoforms of LMNA.
DeBoy E; Puttaraju M; Jailwala P; Kasoji M; Cam M; Misteli T
Nucleus; 2017 Sep; 8(5):573-582. PubMed ID: 28857661
[TBL] [Abstract][Full Text] [Related]
5. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress.
Paradisi M; McClintock D; Boguslavsky RL; Pedicelli C; Worman HJ; Djabali K
BMC Cell Biol; 2005 Jun; 6():27. PubMed ID: 15982412
[TBL] [Abstract][Full Text] [Related]
6. Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS).
Plasilova M; Chattopadhyay C; Ghosh A; Wenzel F; Demougin P; Noppen C; Schaub N; Szinnai G; Terracciano L; Heinimann K
PLoS One; 2011; 6(6):e21433. PubMed ID: 21738662
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
[TBL] [Abstract][Full Text] [Related]
8. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition.
Glynn MW; Glover TW
Hum Mol Genet; 2005 Oct; 14(20):2959-69. PubMed ID: 16126733
[TBL] [Abstract][Full Text] [Related]
9. Investigation of age-related changes in LMNA splicing and expression of progerin in human skeletal muscles.
Luo YB; Mitrpant C; Johnsen RD; Fabian VA; Fletcher S; Mastaglia FL; Wilton SD
Int J Clin Exp Pathol; 2013; 6(12):2778-86. PubMed ID: 24294364
[TBL] [Abstract][Full Text] [Related]
10. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome.
Scaffidi P; Misteli T
Nat Med; 2005 Apr; 11(4):440-5. PubMed ID: 15750600
[TBL] [Abstract][Full Text] [Related]
11. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
[TBL] [Abstract][Full Text] [Related]
12. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.
Lee SJ; Jung YS; Yoon MH; Kang SM; Oh AY; Lee JH; Jun SY; Woo TG; Chun HY; Kim SK; Chung KJ; Lee HY; Lee K; Jin G; Na MK; Ha NC; Bárcena C; Freije JM; López-Otín C; Song GY; Park BJ
J Clin Invest; 2016 Oct; 126(10):3879-3893. PubMed ID: 27617860
[TBL] [Abstract][Full Text] [Related]
13. New Lmna knock-in mice provide a molecular mechanism for the 'segmental aging' in Hutchinson-Gilford progeria syndrome.
Jung HJ; Tu Y; Yang SH; Tatar A; Nobumori C; Wu D; Young SG; Fong LG
Hum Mol Genet; 2014 Mar; 23(6):1506-15. PubMed ID: 24203701
[TBL] [Abstract][Full Text] [Related]
14. Truncated prelamin A expression in HGPS-like patients: a transcriptional study.
Barthélémy F; Navarro C; Fayek R; Da Silva N; Roll P; Sigaudy S; Oshima J; Bonne G; Papadopoulou-Legbelou K; Evangeliou AE; Spilioti M; Lemerrer M; Wevers RA; Morava E; Robaglia-Schlupp A; Lévy N; Bartoli M; De Sandre-Giovannoli A
Eur J Hum Genet; 2015 Aug; 23(8):1051-61. PubMed ID: 25649378
[TBL] [Abstract][Full Text] [Related]
15. A conserved splicing mechanism of the LMNA gene controls premature aging.
Lopez-Mejia IC; Vautrot V; De Toledo M; Behm-Ansmant I; Bourgeois CF; Navarro CL; Osorio FG; Freije JM; Stévenin J; De Sandre-Giovannoli A; Lopez-Otin C; Lévy N; Branlant C; Tazi J
Hum Mol Genet; 2011 Dec; 20(23):4540-55. PubMed ID: 21875900
[TBL] [Abstract][Full Text] [Related]
16. Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr/Cas Technology as A Promising Innovative Treatment Approach.
Rajeev M; Ratan C; Krishnan K; Vijayan M
Recent Pat Biotechnol; 2021; 15(4):266-285. PubMed ID: 34602042
[TBL] [Abstract][Full Text] [Related]
17. Molecular insights into the premature aging disease progeria.
Vidak S; Foisner R
Histochem Cell Biol; 2016 Apr; 145(4):401-17. PubMed ID: 26847180
[TBL] [Abstract][Full Text] [Related]
18. Enhanced SRSF5 Protein Expression Reinforces Lamin A mRNA Production in HeLa Cells and Fibroblasts of Progeria Patients.
Vautrot V; Aigueperse C; Oillo-Blanloeil F; Hupont S; Stevenin J; Branlant C; Behm-Ansmant I
Hum Mutat; 2016 Mar; 37(3):280-91. PubMed ID: 26670336
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic functions of LMNA isoforms in energy expenditure and lifespan.
Lopez-Mejia IC; de Toledo M; Chavey C; Lapasset L; Cavelier P; Lopez-Herrera C; Chebli K; Fort P; Beranger G; Fajas L; Amri EZ; Casas F; Tazi J
EMBO Rep; 2014 May; 15(5):529-39. PubMed ID: 24639560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
